These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 28453784)

  • 1. Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients.
    Figueroa JM; Skog J; Akers J; Li H; Komotar R; Jensen R; Ringel F; Yang I; Kalkanis S; Thompson R; LoGuidice L; Berghoff E; Parsa A; Liau L; Curry W; Cahill D; Bettegowda C; Lang FF; Chiocca EA; Henson J; Kim R; Breakefield X; Chen C; Messer K; Hochberg F; Carter BS
    Neuro Oncol; 2017 Oct; 19(11):1494-1502. PubMed ID: 28453784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas.
    van den Bent MJ; Gao Y; Kerkhof M; Kros JM; Gorlia T; van Zwieten K; Prince J; van Duinen S; Sillevis Smitt PA; Taphoorn M; French PJ
    Neuro Oncol; 2015 Jul; 17(7):935-41. PubMed ID: 25691693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature.
    Akbari H; Bakas S; Pisapia JM; Nasrallah MP; Rozycki M; Martinez-Lage M; Morrissette JJD; Dahmane N; O'Rourke DM; Davatzikos C
    Neuro Oncol; 2018 Jul; 20(8):1068-1079. PubMed ID: 29617843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas.
    Furuta T; Negoto T; Miyoshi H; Moritsubo M; Nakamura H; Morioka M; Akiba J; Ohshima K; Sugita Y
    J Neurooncol; 2023 Sep; 164(3):633-641. PubMed ID: 37710025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serum extracellular vesicles as noninvasive diagnostic markers of glioma.
    Wang H; Jiang D; Li W; Xiang X; Zhao J; Yu B; Wang C; He Z; Zhu L; Yang Y
    Theranostics; 2019; 9(18):5347-5358. PubMed ID: 31410219
    [No Abstract]   [Full Text] [Related]  

  • 6. Large and small extracellular vesicles released by glioma cells
    Yekula A; Minciacchi VR; Morello M; Shao H; Park Y; Zhang X; Muralidharan K; Freeman MR; Weissleder R; Lee H; Carter B; Breakefield XO; Di Vizio D; Balaj L
    J Extracell Vesicles; 2020; 9(1):1689784. PubMed ID: 31839905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Functionalized Superlattice Nanosensor Enables Glioblastoma Diagnosis Using Liquid Biopsy.
    Premachandran S; Haldavnekar R; Ganesh S; Das S; Venkatakrishnan K; Tan B
    ACS Nano; 2023 Oct; 17(20):19832-19852. PubMed ID: 37824714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between EGFR amplification and the expression of microRNA-200c in primary glioblastoma multiforme.
    Serna E; Lopez-Gines C; Monleon D; Muñoz-Hidalgo L; Callaghan RC; Gil-Benso R; Martinetto H; Gregori-Romero A; Gonzalez-Darder J; Cerda-Nicolas M
    PLoS One; 2014; 9(7):e102927. PubMed ID: 25058589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating extracellular vesicles as biomarker for diagnosis, prognosis, and monitoring in glioblastoma patients.
    Ricklefs FL; Wollmann K; Salviano-Silva A; Drexler R; Maire CL; Kaul MG; Reimer R; Schüller U; Heinemann S; Kolbe K; Mummert T; Glatzel M; Peine S; Gempt J; Westphal M; Dührsen L; Lamszus K
    Neuro Oncol; 2024 Jul; 26(7):1280-1291. PubMed ID: 38567448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFRvIII expression triggers a metabolic dependency and therapeutic vulnerability sensitive to autophagy inhibition.
    Jutten B; Keulers TG; Peeters HJM; Schaaf MBE; Savelkouls KGM; Compter I; Clarijs R; Schijns OEMG; Ackermans L; Teernstra OPM; Zonneveld MI; Colaris RME; Dubois L; Vooijs MA; Bussink J; Sotelo J; Theys J; Lammering G; Rouschop KMA
    Autophagy; 2018; 14(2):283-295. PubMed ID: 29377763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteome profiling of salivary small extracellular vesicles in glioblastoma patients.
    Müller Bark J; Trevisan França de Lima L; Zhang X; Broszczak D; Leo PJ; Jeffree RL; Chua B; Day BW; Punyadeera C
    Cancer; 2023 Sep; 129(18):2836-2847. PubMed ID: 37254878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping.
    Lane R; Simon T; Vintu M; Solkin B; Koch B; Stewart N; Benstead-Hume G; Pearl FMG; Critchley G; Stebbing J; Giamas G
    Commun Biol; 2019; 2():315. PubMed ID: 31453379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bio-Inspired NanoVilli Chips for Enhanced Capture of Tumor-Derived Extracellular Vesicles: Toward Non-Invasive Detection of Gene Alterations in Non-Small Cell Lung Cancer.
    Dong J; Zhang RY; Sun N; Smalley M; Wu Z; Zhou A; Chou SJ; Jan YJ; Yang P; Bao L; Qi D; Tang X; Tseng P; Hua Y; Xu D; Kao R; Meng M; Zheng X; Liu Y; Vagner T; Chai X; Zhou D; Li M; Chiou SH; Zheng G; Di Vizio D; Agopian VG; Posadas E; Jonas SJ; Ju SP; Weiss PS; Zhao M; Tseng HR; Zhu Y
    ACS Appl Mater Interfaces; 2019 Apr; 11(15):13973-13983. PubMed ID: 30892008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel EGFR variant EGFRx maintains glioblastoma stem cells through STAT5.
    Huang W; Li J; Zhu H; Qin X; Chen C; Wang B; Wei J; Song Y; Lu X; Li Z; Xia W; He A; Cheng L; Yu X; Shu K; Wang W
    Neuro Oncol; 2024 Jan; 26(1):85-99. PubMed ID: 37616578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles from genetically unstable, oncogene-driven cancer cells trigger micronuclei formation in endothelial cells.
    Chennakrishnaiah S; Tsering T; Gregory C; Tawil N; Spinelli C; Montermini L; Karatzas N; Aprikian S; Choi D; Klewes L; Mai S; Rak J
    Sci Rep; 2020 May; 10(1):8532. PubMed ID: 32444772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development.
    Akers JC; Ramakrishnan V; Kim R; Skog J; Nakano I; Pingle S; Kalinina J; Hua W; Kesari S; Mao Y; Breakefield XO; Hochberg FH; Van Meir EG; Carter BS; Chen CC
    PLoS One; 2013; 8(10):e78115. PubMed ID: 24205116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patients.
    Yekula A; Hsia T; Kitchen RR; Chakrabortty SK; Yu W; Batool SM; Lewis B; Szeglowski AJ; Weissleder R; Lee H; Chi AS; Batchelor T; Carter BS; Breakefield XO; Skog J; Balaj L
    Neurooncol Adv; 2023; 5(1):vdad104. PubMed ID: 37811539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancements and Technical Considerations for Extracellular Vesicle Isolation and Biomarker Identification in Glioblastoma.
    Cumba Garcia LM; Bouchal SM; Bauman MMJ; Parney IF
    Neurosurgery; 2023 Jul; 93(1):33-42. PubMed ID: 36749103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal glioma stem cells trigger vasectasia-distinct neovascularization process stimulated by extracellular vesicles carrying EGFR.
    Spinelli C; Adnani L; Meehan B; Montermini L; Huang S; Kim M; Nishimura T; Croul SE; Nakano I; Riazalhosseini Y; Rak J
    Nat Commun; 2024 Apr; 15(1):2865. PubMed ID: 38570528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current insights on extracellular vesicle-mediated glioblastoma progression: Implications in drug resistance and epithelial-mesenchymal transition.
    Mukherjee S; Pillai PP
    Biochim Biophys Acta Gen Subj; 2022 Mar; 1866(3):130065. PubMed ID: 34902452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.